Abstract | BACKGROUND: CASE PRESENTATION: CONCLUSION:
Breast cancer overexpressing HER2 is a malignant tumor responsible for many cancer-related deaths. The combination of pyrotinib plus other targeted chemotherapy can dramatically improve the outcome of locally advanced disease.
|
Authors | Lina He, Fengchun Zhang, Yue Ma, Li Zuo, Yingchun Xu |
Journal | OncoTargets and therapy
(Onco Targets Ther)
Vol. 13
Pg. 8749-8756
( 2020)
ISSN: 1178-6930 [Print] New Zealand |
PMID | 32943881
(Publication Type: Case Reports)
|
Copyright | © 2020 He et al. |